FRP-2 Activators
FRP-2 activators constitute a class of chemicals selected for their potential to modulate the activity of FRP-2, a protein intricately involved in cellular processes such as cell proliferation, survival, and migration. While direct activators may not be explicitly identified, these chemicals exert their effects through indirect mechanisms, primarily by targeting key kinases and pathways associated with FRP-2 regulation. The Ras/Raf/MEK/ERK signaling pathway stands out as a central player in the indirect activation of FRP-2. Chemicals like GW5074, U0126, PD98059, and Sorafenib selectively inhibit components of this pathway, such as Raf and MEK, thereby modulating FRP-2 activation. The disruption of Ras/Raf/MEK/ERK signaling cascades influences downstream events, potentially altering FRP-2's role in cellular processes related to proliferation and survival.
Additionally, the class includes inhibitors targeting other key kinases. PP1, a selective inhibitor of Src family kinases, indirectly modulates FRP-2 by disrupting Src-dependent events. SP600125 and SB 203580, inhibitors of JNK and p38 MAPK, respectively, illustrate the intricate web of signaling pathways governing FRP-2 activation. These chemicals influence downstream events, possibly leading to the activation of FRP-2 in response to changes in JNK- and p38 MAPK-mediated signaling cascades. Furthermore, inhibitors like Y-27632, Wortmannin, LY294002, Calphostin C, and LY333531 target Rho-associated protein kinase (ROCK), PI3K, and protein kinase C (PKC) family members. These chemicals impact various cellular processes related to FRP-2, including cell adhesion, migration, and survival. The disruption of ROCK, PI3K, and PKC-dependent cascades alters the regulatory mechanisms governing FRP-2, providing insights into potential pharmacological interventions for studying its role in cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a selective inhibitor of Raf-1 kinase, a key component of the Ras/Raf/MEK/ERK signaling pathway. By inhibiting Raf-1, GW5074 can indirectly influence FRP-2 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK1 in the Ras/Raf/MEK/ERK pathway. By inhibiting MEK1, PD98059 can indirectly impact FRP-2 activation. The Ras/Raf/MEK/ERK pathway plays a crucial role in cellular signaling, and interference with MEK1 can influence downstream events, potentially altering FRP-2's role in cellular processes related to cell proliferation and survival. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multi-kinase inhibitor that targets Raf kinases among others. By inhibiting Raf, Sorafenib can indirectly modulate FRP-2 activation. The complex kinase inhibition profile of Sorafenib affects multiple signaling pathways, potentially influencing FRP-2's role in cellular processes related to angiogenesis, proliferation, and survival. | ||||||
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
PP1 is a selective inhibitor of Src family kinases, which can indirectly influence FRP-2 activation. Src kinases are involved in various cellular pathways, and the inhibition of Src family kinases by PP1 may impact downstream events, altering FRP-2's role in cellular processes related to cell proliferation and survival. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of c-Jun N-terminal kinase (JNK), a kinase implicated in cellular signaling pathways involving FRP-2. By inhibiting JNK, SP600125 may indirectly activate FRP-2 through modulation of downstream JNK-dependent events. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK), a kinase implicated in cellular signaling pathways involving FRP-2. By inhibiting p38 MAPK, SB 203580 may indirectly activate FRP-2 through modulation of downstream p38 MAPK-dependent events. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinase (PI3K), a kinase involved in cellular processes including those related to FRP-2 regulation. By inhibiting PI3K, Wortmannin can indirectly modulate FRP-2 activation, impacting downstream signaling events. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of phosphoinositide 3-kinase (PI3K) that can indirectly influence FRP-2 activation. Similar to Wortmannin, LY294002 disrupts PI3K-dependent cascades, potentially altering the regulatory mechanisms governing FRP-2 and its participation in cellular processes related to cell proliferation and survival. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C is a potent inhibitor of protein kinase C (PKC), a kinase involved in various cellular processes, including those associated with FRP-2 regulation. By inhibiting PKC, Calphostin C can indirectly modulate FRP-2 activation, impacting downstream signaling events. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
LY333531 is a specific inhibitor of protein kinase C beta (PKCβ), a kinase involved in various cellular processes, including those associated with FRP-2 regulation. By inhibiting PKCβ, LY333531 can indirectly modulate FRP-2 activation, impacting downstream signaling events. | ||||||